Fort L.P. raised its stake in Prestige Consumer Healthcare Inc (NYSE:PBH) by 66.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 83,096 shares of the company’s stock after buying an additional 33,236 shares during the quarter. Fort L.P.’s holdings in Prestige Consumer Healthcare were worth $3,189,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently bought and sold shares of PBH. Wells Fargo & Company MN lifted its position in Prestige Consumer Healthcare by 46.4% in the first quarter. Wells Fargo & Company MN now owns 1,837,285 shares of the company’s stock valued at $61,954,000 after buying an additional 582,373 shares during the last quarter. Alps Advisors Inc. lifted its position in Prestige Consumer Healthcare by 43.1% in the first quarter. Alps Advisors Inc. now owns 13,355 shares of the company’s stock valued at $450,000 after buying an additional 4,024 shares during the last quarter. SG Americas Securities LLC lifted its position in Prestige Consumer Healthcare by 103.2% in the first quarter. SG Americas Securities LLC now owns 16,597 shares of the company’s stock valued at $560,000 after buying an additional 8,431 shares during the last quarter. Meeder Asset Management Inc. acquired a new position in Prestige Consumer Healthcare in the first quarter valued at about $683,000. Finally, Victory Capital Management Inc. lifted its position in Prestige Consumer Healthcare by 37.8% in the first quarter. Victory Capital Management Inc. now owns 7,922 shares of the company’s stock valued at $267,000 after buying an additional 2,175 shares during the last quarter.
Shares of NYSE:PBH opened at $38.38 on Friday. The company has a debt-to-equity ratio of 1.72, a quick ratio of 1.37 and a current ratio of 2.21. The stock has a market cap of $1.97 billion, a price-to-earnings ratio of 14.61, a price-to-earnings-growth ratio of 1.91 and a beta of 1.04. Prestige Consumer Healthcare Inc has a 1 year low of $27.84 and a 1 year high of $51.79.
Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings results on Thursday, August 2nd. The company reported $0.68 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.67 by $0.01. The company had revenue of $253.98 million for the quarter, compared to analyst estimates of $253.70 million. Prestige Consumer Healthcare had a net margin of 32.76% and a return on equity of 12.45%. The business’s revenue for the quarter was down 1.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.66 earnings per share. analysts anticipate that Prestige Consumer Healthcare Inc will post 2.86 EPS for the current fiscal year.
A number of research firms have commented on PBH. Zacks Investment Research cut shares of Prestige Consumer Healthcare from a “hold” rating to a “sell” rating in a research report on Friday, May 11th. Jefferies Financial Group set a $38.00 target price on shares of Prestige Consumer Healthcare and gave the company a “hold” rating in a research report on Thursday, August 2nd. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of $69.00.
About Prestige Consumer Healthcare
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.
Read More: Marijuana Stocks Investing Considerations
Want to see what other hedge funds are holding PBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Prestige Consumer Healthcare Inc (NYSE:PBH).
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.